Fig 1.
Study flowchart depicting patient inclusion criteria.
Table 1.
ESBL-status-stratified clinicodemographic and laboratory characteristics of patients with acute cholangitis.
Table 2.
Clinical outcomes and microbiological findings in patients with acute cholangitis.
Table 3.
Empirical antimicrobials used in patients with acute cholangitis.
Table 4.
Distribution of Gram-negative pathogens isolated from blood and bile samples in patients with acute cholangitis.
Fig 2.
Multivariate logistic regression analysis of predictors for ESBL-positive status in acute cholangitis.
Table 5.
Final multivariable logistic regression model and assigned scores for ESBL risk stratification in acute cholangitis.
Table 6.
Performance metrics of the scoring system for predicting ESBL-positivity status in patients with acute cholangitis.
Fig 3.
Visualization of predicted probability for ESBL-positive status using the scoring system.